Maximilian Pistor

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Multiple Sclerosis

Top Venues

Annals of the rheumatic diseases

Therapeutic advances in neurological disorders

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Maximilian Pistor, Helly N Hammer, Salmen Anke, Robert Hoepner, Christoph Friedli
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort. CNS neuroscience & therapeutics 28 (5) (2022)
Maximilian Pistor, Robert Hoepner, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Andrew Chan, Salmen Anke
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System. Therapeutic advances in neurological disorders 15 (2022)
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Andrew Chan, Anke Salmen, Robert Hoepner
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Annals of the rheumatic diseases 80 (12) (2021)
Maud Bagnoud, Myriam Briner, Jana Remlinger, Ivo Meli, Sara Schuetz, Maximilian Pistor, Salmen Anke, Andrew Chan, Robert Hoepner
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells 9 (10) (2020)